364 related articles for article (PubMed ID: 25640819)
1. Teratoma formation: a tool for monitoring pluripotency in stem cell research.
Nelakanti RV; Kooreman NG; Wu JC
Curr Protoc Stem Cell Biol; 2015 Feb; 32():4A.8.1-4A.8.17. PubMed ID: 25640819
[TBL] [Abstract][Full Text] [Related]
2. Teratoma Formation Assay for Assessing Pluripotency and Tumorigenicity of Pluripotent Stem Cells.
Miyawaki S; Okada Y; Okano H; Miura K
Bio Protoc; 2017 Aug; 7(16):e2518. PubMed ID: 34541178
[TBL] [Abstract][Full Text] [Related]
3. Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency.
Gertow K; Przyborski S; Loring JF; Auerbach JM; Epifano O; Otonkoski T; Damjanov I; Ahrlund-Richter L
Curr Protoc Stem Cell Biol; 2007 Oct; Chapter 1():Unit1B.4. PubMed ID: 18785162
[TBL] [Abstract][Full Text] [Related]
4. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
[TBL] [Abstract][Full Text] [Related]
5. Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas.
Damjanov I; Andrews PW
Int J Dev Biol; 2016; 60(10-11-12):337-419. PubMed ID: 28000905
[TBL] [Abstract][Full Text] [Related]
6. The teratoma assay: an in vivo assessment of pluripotency.
Wesselschmidt RL
Methods Mol Biol; 2011; 767():231-41. PubMed ID: 21822879
[TBL] [Abstract][Full Text] [Related]
7. Teratoma Assay for Testing Pluripotency and Malignancy of Stem Cells: Insufficient Reporting and Uptake of Animal-Free Methods-A Systematic Review.
Montilla-Rojo J; Bialecka M; Wever KE; Mummery CL; Looijenga LHJ; Roelen BAJ; Salvatori DCF
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835305
[TBL] [Abstract][Full Text] [Related]
8. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
[TBL] [Abstract][Full Text] [Related]
9. Teratoma: from spontaneous tumors to the pluripotency/malignancy assay.
Bulic-Jakus F; Katusic Bojanac A; Juric-Lekic G; Vlahovic M; Sincic N
Wiley Interdiscip Rev Dev Biol; 2016; 5(2):186-209. PubMed ID: 26698368
[TBL] [Abstract][Full Text] [Related]
10. Isolation of pluripotent neural crest-derived stem cells from adult human tissues by connexin-43 enrichment.
Pelaez D; Huang CY; Cheung HS
Stem Cells Dev; 2013 Nov; 22(21):2906-14. PubMed ID: 23750535
[TBL] [Abstract][Full Text] [Related]
11. Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny.
Gropp M; Shilo V; Vainer G; Gov M; Gil Y; Khaner H; Matzrafi L; Idelson M; Kopolovic J; Zak NB; Reubinoff BE
PLoS One; 2012; 7(9):e45532. PubMed ID: 23049812
[TBL] [Abstract][Full Text] [Related]
12. Teratoma generation in the testis capsule.
Peterson SE; Tran HT; Garitaonandia I; Han S; Nickey KS; Leonardo T; Laurent LC; Loring JF
J Vis Exp; 2011 Nov; (57):e3177. PubMed ID: 22158256
[TBL] [Abstract][Full Text] [Related]
13. Functional assays for human embryonic stem cell pluripotency.
O'Connor MD; Kardel MD; Eaves CJ
Methods Mol Biol; 2011; 690():67-80. PubMed ID: 21042985
[TBL] [Abstract][Full Text] [Related]
14. Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel.
Prokhorova TA; Harkness LM; Frandsen U; Ditzel N; Schrøder HD; Burns JS; Kassem M
Stem Cells Dev; 2009; 18(1):47-54. PubMed ID: 18393673
[TBL] [Abstract][Full Text] [Related]
15. Teratoma formation in immunocompetent mice after syngeneic and allogeneic implantation of germline capable mouse embryonic stem cells.
Aldahmash A; Atteya M; Elsafadi M; Al-Nbaheen M; Al-Mubarak HA; Vishnubalaji R; Al-Roalle A; Al-Harbi S; Manikandan M; Matthaei KI; Mahmood A
Asian Pac J Cancer Prev; 2013; 14(10):5705-11. PubMed ID: 24289566
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent stem cells derived from mouse and human white mature adipocytes.
Jumabay M; Abdmaulen R; Ly A; Cubberly MR; Shahmirian LJ; Heydarkhan-Hagvall S; Dumesic DA; Yao Y; Boström KI
Stem Cells Transl Med; 2014 Feb; 3(2):161-71. PubMed ID: 24396033
[TBL] [Abstract][Full Text] [Related]
17. Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays.
Bouma MJ; van Iterson M; Janssen B; Mummery CL; Salvatori DCF; Freund C
Stem Cell Reports; 2017 May; 8(5):1340-1353. PubMed ID: 28494940
[TBL] [Abstract][Full Text] [Related]
18. Variation in the incidence of teratomas after the transplantation of nonhuman primate ES cells into immunodeficient mice.
Kishi Y; Tanaka Y; Shibata H; Nakamura S; Takeuchi K; Masuda S; Ikeda T; Muramatsu S; Hanazono Y
Cell Transplant; 2008; 17(9):1095-102. PubMed ID: 19177845
[TBL] [Abstract][Full Text] [Related]
19. Testicular teratomas: an intersection of pluripotency, differentiation and cancer biology.
Bustamante-Marín X; Garness JA; Capel B
Int J Dev Biol; 2013; 57(2-4):201-10. PubMed ID: 23784831
[TBL] [Abstract][Full Text] [Related]
20. Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.
Dressel R; Guan K; Nolte J; Elsner L; Monecke S; Nayernia K; Hasenfuss G; Engel W
Biol Direct; 2009 Aug; 4():31. PubMed ID: 19715575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
